510(k) Report

510(k) · Cleared

Cleared

Hyperion X9

K123381510(k) TraditionalCleared May 10, 2013190-day reviewClass II21 CFR 892.1750

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cefla S.C. · OAS X-Ray, Tomography, Computed, Dental

Cleared on May 10, 2013 after a 190-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 11 later devices descend from it.

Decided
May 10, 2013
Review
190 days
Class
Class II
Product code
OAS
Recalls
None
Predicates
0

11 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2015: 2 descendants cleared2016: 3 descendants cleared2022: 1 descendant cleared2020: 3 descendants cleared2023: 1 descendant cleared2025: 1 descendant cleared2010201520202025
  1. This deviceK123381 Hyperion X9Cefla S.C. · 2013
  2. Descendant · cites it directly · 4 of its ownK150354 PAPAYA 3D PlusGenoray Co., Ltd. · 2015
  3. Descendant · cites it directly · 3 of its ownK160166 X-MIND triumDe Gotzen S.R.L. · 2016
  4. Descendant · 2 generations on · 1 of its ownK200469 PAPAYA 3D Premium & PAPAYA 3D Premium PlusGenoray Co., Ltd. · 2020
  5. Descendant · cites it directly · 1 of its ownK152162 Myray- HYPERION X5Cefla S.C. · 2015
  6. Descendant · 3 generations on · 0 of its ownK250060 GT300; GT300-CGenoray Co., Ltd. · 2025

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

2015: 22016: 32020: 32022: 12023: 12025: 1
2015high 3 (2016) · low 0 (2017)2026

Most influential descendants

Showing 5 of 11 · See all
  • K150354PAPAYA 3D PlusGenoray Co., Ltd. · 2015 · cites it directly4descendants
  • K160166X-MIND triumDe Gotzen S.R.L. · 2016 · cites it directly3descendants
  • K200469PAPAYA 3D Premium & PAPAYA 3D Premium PlusGenoray Co., Ltd. · 2020 · 2 generations on1descendant
  • K152162Myray- HYPERION X5Cefla S.C. · 2015 · cites it directly1descendant
  • K250060GT300; GT300-CGenoray Co., Ltd. · 2025 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K123381Hyperion X9Cefla S.C.2013—
+1K150354PAPAYA 3D PlusGenoray Co., Ltd.2015—
+1K160166X-MIND triumDe Gotzen S.R.L.2016—
+2K200469PAPAYA 3D Premium & PAPAYA 3D Premium PlusGenoray Co., Ltd.2020—
+1K152162Myray- HYPERION X5Cefla S.C.2015—
+3K250060GT300; GT300-CGenoray Co., Ltd.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201520
201630
202030
202210
202310
202510
FIG. 1 — Lineage of K123381, 2013–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OAS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OAS device

  1. #1 K213226 RCT700score 18.0 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (11)

See all 11

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K150354PAPAYA 3D PlusGenoray Co., Ltd.20154
K160166X-MIND triumDe Gotzen S.R.L.20163
K152162Myray- HYPERION X5Cefla S.C.20151
K161900Hyperion X5Cefla S.C.20160

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K150354 (Genoray Co., Ltd., 2015) has gone furthest, with 4 descendants of its own.

How does its category compare?

All OAS devices

OAS X-Ray, Tomography, Computed, Dental: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · OAS

9in 2025

2007: 22008: 22009: 22010: 12011: 62012: 72013: 102014: 52015: 52016: 122017: 42018: 112019: 72020: 92021: 112022: 62023: 122024: 42025: 92026 (partial year): 9
2007high 12 (2016) · low 1 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OAS

144in 2025

2011: 168 days median2012: 110 days median2013: 155 days median2014: 170 days median2015: 164 days median2016: 154 days median2017: 209 days median2018: 57 days median2019: 55 days median2020: 113 days median2021: 92 days median2022: 105 days median2023: 77 days median2024: 129 days median2025: 144 days median2026 (partial year): 77 days median
2007high 209 (2017) · low 55 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OAS

3in 2025

2015: 12025: 3
2007high 3 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OAS

1in 2025

2008: 12019: 12022: 12023: 12024: 22025: 1
2007high 2 (2024) · low 0 (2007)2025

MAUDE reports naming product code OAS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—01
20092—00
20101—00
2011616800
2012711000
20131015500
2014517000
2015516410
20161215400
2017420900
2018115700
201975501
2020911300
2021119200
2022610501
2023127701
2024412902
2025914431
20269770—

What is it indicated for?

Hyperion X9 is a digital panoramic, cephalometric and tomographic extra-oral X-ray system, indicated for use in: (i) producing panoramic X-ray images of the maxillofacial area, for diagnostic examination of dentition (teeth), jaws and oral structures; and (ii) producing radiographs of jaws, parts of the skull and carpus for the purpose of cephalometric examination, when equipped with tele-radiographic arm (CEPH); (iii) producing tomographic images of the…

Read the full statement (133 words)

Hyperion X9 is a digital panoramic, cephalometric and tomographic extra-oral X-ray system, indicated for use in:

(i) producing panoramic X-ray images of the maxillofacial area, for diagnostic examination of dentition (teeth), jaws and oral structures; and

(ii) producing radiographs of jaws, parts of the skull and carpus for the purpose of cephalometric examination, when equipped with tele-radiographic arm (CEPH);

(iii) producing tomographic images of the oral and maxillofacial structure, for diagnostic examination of dentition (teeth), jaws ,oral structures and some cranial bones if equipped with CBiCT option.

The system accomplishes tomographic exam by acquiring a 360-dlegree rotational X-ray sequence of images and reconstructing a three-dimensional matrix of the examined volume, producing two-dimensional views of this volume and displaying both two dimensional images and three-dimensional renderings. This technique is known as CBCT or CB33D.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K123381: Hyperion X9.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K123381

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026